{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:21:04Z","timestamp":1790706064537,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Special Care in Dentistry"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>There is growing evidence that anti\u2010resorptive and anti\u2010angiogenic medications can cause medication\u2010related osteonecrosis of the external auditory canal (MROEAC). It is possible that patients taking risk medications may also suffer from concomitant medication \u2010related osteonecrosis of the jaw (MRONJ) or temporomandibular joint\u00a0(TMJ) involvement. The aim of this paper is to conduct a rapid review of the literature on MROEAC, and, its relevance to special care dentists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Results<\/jats:title><jats:p>A rapid review of the literature was carried out using PubMed, Science Direct and Google Scholar to identify papers relating to MROEAC. The grey literature and non\u2010English papers were also consulted. Overall, 19 papers were identified from 2005 until December 2022.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients at risk of MRONJ may also be at risk of MROEAC and present to special care dentists. Dental\/orofacial disease may cause signs and symptoms suggestive of MROEAC. It should be considered as a potential cause of orofacial pain in special care patients. MROEAC can have a significant impact on a patient's dental treatment, including access, the provision of sedation, communication difficulties, and consent issues.<\/jats:p><\/jats:sec>","DOI":"10.1111\/scd.12893","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T16:19:15Z","timestamp":1688055555000},"page":"314-327","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medication\u2010related osteonecrosis of the external auditory canal \u2013 A rapid review of the literature and relevance to special care dentists"],"prefix":"10.1111","volume":"44","author":[{"given":"Ishfaq","family":"Khan","sequence":"first","affiliation":[{"name":"School of Dentistry College of Medical and Dental Sciences University of Birmingham Birmingham UK"},{"name":"Midlands Partnership University NHS Foundation Trust Dental Services St George's Hospital Staffordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e318268d1b3"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"e_1_2_8_4_1","unstructured":"www.sdcep.org.uk. UK: Scottish Dental Clinical Effectiveness Programme. Oral health management of patients at risk of medication\u2010 related osteonecrosis of the jaw. 2017. [Cited 2022 June 16]. Available from:\u00a0https:\/\/www.sdcep.org.uk\/published-guidance\/medication-related-osteonecrosis-of-the-jaw\/"},{"key":"e_1_2_8_5_1","unstructured":"www.rcplondon.ac.uk. UK: Royal College of Physicians. Medication\u2010Related osteonecrosis of the jaw. Guidance for the oncology multidisciplinary team. Report of Working Party on behalf of the UK chemotherapy board.2019. [Cited 2022 November 15]. Available from:https:\/\/www.rcplondon.ac.uk\/guidelines\u2010policy\/medication\u2010related\u2010osteonecrosis\u2010jaw\u2010guidance\u2010oncology\u2010multidisciplinary\u2010team"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.23191"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4468"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2016.05.002"},{"key":"e_1_2_8_9_1","volume-title":"BNF 84. (British National Formulary): September 2022 \u2013 March 2023","author":"Joint Formulary Committee","year":"2022"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41415-020-1422-0"},{"key":"e_1_2_8_11_1","unstructured":"WebMD.com. USA: Web MD. [Cited 2022 June 03]. Available from:www.webmd.com\/cancer\/cancer\u2010angiogenesis\u2010inhibitors"},{"key":"e_1_2_8_12_1","article-title":"Denosumab\u2010related osteonecrosis of the external auditory canal\u2014benefit of the early surgical management","volume":"21","author":"Pe\u0159ina V","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"e_1_2_8_13_1","unstructured":"GOV.UK. UK: MHRA. Denosumab(Prolia Xgeva\u25bc): reports of osteonecrosis of the external auditory canal. [Cited 2022 April 07]. Available from:https:\/\/www.gov.uk\/drug\u2010safety\u2010update\/denosumab\u2010prolia\u2010xgeva\u2010reports\u2010of\u2010osteonecrosis\u2010of\u2010the\u2010external\u2010auditory\u2010canal"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.14201\/orl.20961"},{"key":"e_1_2_8_15_1","unstructured":"GarrittyC GartlehnerG KamelC et\u00a0al.Cochrane rapid reviews.Interim guidance from the cochrane rapid reviews methods group.2020. [Cited 2022 June 03]. Available from:methods.cochrane.org\/sites\/methods.cochrane.org.rapidreviews\/files\/uploads\/cochrane_rr_\u2010_guidance\u201023mar2020\u2010v1.pdf"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05833.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2018-110990"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-011-1496-z"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-012-2554-6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31827ca34d"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e3182a24846"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2013.02.013"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1017\/S002221511300100X"},{"key":"e_1_2_8_24_1","first-page":"3","article-title":"Bisphosphonate\u2010induced osteonecrosis of the external auditory canal: a case report","volume":"2","author":"Thorsteinsson AL","year":"2015","journal-title":"J Clin Med Case Reports"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/23772484.2017.1350110"},{"key":"e_1_2_8_26_1","first-page":"355","article-title":"A case of osteonecrosis of the external auditory canal as a possible side effect of bisphosphonates","volume":"89","author":"\u5c0f\u51fa \u5343\u79cb, \u7a42\u82c5 \u8c4a. \u30d3\u30b9\u30db\u30b9\u30db\u30cd\u30fc\u30c8\u306e\u526f\u4f5c\u7528\u3068\u8003\u3048\u3089\u308c\u305f\u5916\u8033\u9053\u9aa8\u58ca\u6b7b\u306e1\u4f8b. \u8033\u9f3b\u54bd\u5589\u79d1\u30fb\u982d\u9838\u90e8\u5916\u79d189\u5dfb4\u53f7\uff082017\u5e744\u6708\u767a\u884c\uff09 355\u2013359 (Translation: Koide C","year":"2017","journal-title":"Otorhinolaryngology, Head and Neck Surgery"},{"key":"e_1_2_8_27_1","first-page":"905","article-title":"Osteonecrosis of the ear canal thought to be caused by bisphosphonate administration","volume":"121","author":"\u7247\u5ca1\u7950\u5b50, \u91ce\u7530\u5b9f\u91cc, \u5927\u9053\u4eae\u592a\u90ce, \u6e05\u6c34\u85cd\u5b50, \u5047\u8c37\u4f38, \u897f\ufa11\u548c\u5247. \u30d3\u30b9\u30db\u30b9\u30db\u30cd\u30fc\u30c8\u88fd\u5264\u6295\u4e0e\u304c\u539f\u56e0\u3068\u8003\u3048\u3089\u308c\u305f\u5916\u8033\u9053\u9aa8\u58ca\u6b7b. \u65e5\u672c\u8033\u9f3b\u54bd\u5589\u79d1\u5b66\u4f1a\u4f1a\u5831. 2018; 121(7):905\u2013911. (Translation: Kataoka Y","year":"2018","journal-title":"Bulletin of the Japanese Society of Otolaryngology"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215118000324"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000002344"},{"issue":"4","key":"e_1_2_8_30_1","first-page":"617","article-title":"\u5c71\u53e3\u9ad8\u53f2. \u201c\u75c7\u4f8b\u5831\u544a \u9aa8\u5438\u53ce\u6291\u5236\u85ac\u9577\u671f\u4f7f\u7528\u306b\u3088\u308a\u984e\u9aa8\u58ca\u6b7b\u3068\u4e21\u5074\u5916\u8033\u9053\u9aa8\u58ca\u6b7b\u3092\u304d\u305f\u3057\u305f 1 \u4f8b.\u201d\u65e5\u672c\u9aa8\u7c97\u9b06\u75c7\u5b66\u4f1a\u96d1\u8a8c 2019; 5 (4): 617\u2013622\u00a0(Translation: Yamaguchi T. Anti\u2013resorptive agents\u2013related osteonecrosis of the jaw and bilateral external auditory canal: a case report","volume":"5","year":"2019","journal-title":"J Japan Osteoporosis Soc"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241203"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2020.07.007"},{"key":"e_1_2_8_33_1","article-title":"Sunitinib\u2010related osteonecrosis of the external auditory canal: case report","volume":"4","author":"Eguia A","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215122000706"},{"key":"e_1_2_8_35_1","first-page":"27","article-title":"Pamidronic acid\/zoledronic acid osteonecrosis of the external ear canal: 3 case reports","volume":"1366","author":"Froelich K","year":"2011","journal-title":"Reactions"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31827ca34d"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000000401"},{"issue":"172","key":"e_1_2_8_38_1","first-page":"154","article-title":"Bisphosphonates: osteonecrosis of the external auditory canal","volume":"25","year":"2016","journal-title":"Prescrire Int"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1530-891X(20)39599-9"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2022.241203rep"},{"key":"e_1_2_8_41_1","unstructured":"GOV.UK. UK:MHRA. Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal. [Cited 2022 May 11]. Available from:https:\/\/www.gov.uk\/drug\u2010safety\u2010update\/bisphosphonates\u2010very\u2010rare\u2010reports\u2010of\u2010osteonecrosis\u2010of\u2010the\u2010external\u2010auditory\u2010canal"},{"key":"e_1_2_8_42_1","first-page":"783","article-title":"Clinical picture of the ear canal cholesteatoma with a long history of administration of bisphosphonate preparations \u2010examination from the perspective of conservative therapeutic effects","volume":"121","author":"Kanazawa A","year":"2018","journal-title":"Bulletin of the Japanese Society of Otolaryngology"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2684-7"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599814541629a261"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41415-022-4304-9"},{"key":"e_1_2_8_46_1","first-page":"415","article-title":"Hyperbaric oxygen in the therapeutic management of osteoradionecrosis of the facial bones","volume":"65","author":"Vudiniabola S","year":"2007","journal-title":"Int J Oral Maxillofacial Surg"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e3283313cdd"},{"key":"e_1_2_8_48_1","unstructured":"Joanna Briggs Institute. Adelaide: JBI's Tools Assess Trust Relevance & Results of Published Papers: Enhancing Evidence Synthesis | JBI. [Cited 2023 May 05]. Accessed December 01 2022. Available from:https:\/\/jbi.global\/critical\u2010appraisal\u2010tools"},{"key":"e_1_2_8_49_1","unstructured":"KoehnP KnowlesR.Six challenges for neural machine translation. InProceedings of the 1st Workshop on Neural Machine Translation.Association for Computational Linguistics;2017:28\u201339. [Cited 2023 May 05]. Accessed May 03 2023. Available from:http:\/\/www.aclweb.org\/anthology\/W17\u20103204"}],"container-title":["Special Care in Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/scd.12893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:54:09Z","timestamp":1710424449000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/scd.12893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/scd.12893"],"URL":"https:\/\/doi.org\/10.1111\/scd.12893","archive":["Portico"],"relation":{},"ISSN":["0275-1879","1754-4505"],"issn-type":[{"value":"0275-1879","type":"print"},{"value":"1754-4505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"2023-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}